💩Stool Trackers Aim for $106B Market by 2029
Stool Trackers Want a Piece of the $106B Health Pie
TL;DR
Stool trackers like Kohler Health and Throne aim for the $106B gut health market by 2029, but their high price and limited benefits for healthy users raise questions. Are they just a gimmick?
Stool trackers like Kohler Health and Throne are aiming for a $106B gut health market by 2029, but their $449-$399 price tags and $130-$70 annual memberships might not be worth it for most users. These devices use cameras to analyze urine and stool, offering insights on gut health and hydration scores. However, they may not provide new insights for healthy individuals with regular bowel movements. Throne's device also aims to detect blood in fecal matter, potentially spotting colorectal cancer, though its effectiveness compared to medical lab tests is unclear. Both companies claim not to sell user data for advertising but can share it with law enforcement or in mergers. The high cost makes them impractical as cancer screening tools, but they could be useful for specific health concerns.
Key Points
Kohler Health's device costs $449 plus $130 for an annual family membership.
Throne's product is priced at $399 plus $70 for an annual membership.
Both devices use cameras to record videos of deposits and analyze urine and stool consistency and color.
Throne plans to detect blood in fecal matter using multispectral imaging, potentially spotting colorectal cancer.
Kohler Health already alerts users when it detects blood in the toilet, but the cost makes them impractical for widespread cancer screening.
Why It Matters
If you're tracking gut health or hydration scores, these devices offer new insights. However, their high cost and limited benefits for healthy users mean they're not a must-have. For those with specific health concerns, they could be valuable, but the effectiveness of detecting colorectal cancer is still uncertain.
Frequently Asked Questions
Why does this matter?
If you're tracking gut health or hydration scores, these devices offer new insights. However, their high cost and limited benefits for healthy users mean they're not a must-have. For those with specific health concerns, they could be valuable, but the effectiveness of detecting colorectal cancer is still uncertain.
What happened?
Stool trackers like Kohler Health and Throne aim for the $106B gut health market by 2029, but their high price and limited benefits for healthy users raise questions. Are they just a gimmick?
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,463 builders reading daily.